Αποτελέσματα Αναζήτησης
17 Απρ 2024 · A patient’s blood lead level (BLL) is measured in micrograms of lead per deciliter of blood (μg/dL). Healthcare providers should follow recommendations based on initial screening capillary and confirmed venous BLLs. Learn more about the recommended actions after a blood lead level test.
Page 45: Interpreting Patient Test Results. “High” in the display windows indicates a blood lead test result greater than 65 µg/dL. When this occurs, report the blood lead result as greater than (>) 65 µg/dL. “High” results on LeadCare II should be followed up immediately as an emergency laboratory test.
Read all instructions carefully before you perform a blood lead test. This chapter contains important information that you need to know before you use the LeadCare® II Blood Lead Analyzer. Please read the following sections before using the analyzer. Unpacking the LeadCare II Blood Lead Analyzer Setting up the Analyzer
This fact sheet serves to outline quality improvement guidance for the sampling and measurement of blood lead. Lead is found in the ambient environment and care must be taken to avoid contamination of specimen collection and testing supplies and to use practices that do not contaminate the specimen throughout the sampling and testing processes.
This guidance is intended to help clinicians respond to lower BLL results once a blood sample has been collected. The National PEHSU has released a factsheet for clinicians addressing “Recommendations on Medical Management of Childhood Lead Exposure and Poisoning” (April 2013, located at http://www.aoec.
Recommended Actions Based on Blood Lead Level Summary of Recommendations for Follow-up and Case Management for Children. CDC recommends testing blood for lead exposure. Two types of blood collection tests may be used: Capillary sample: A nger-prick or heel-prick is used to take a small amount of blood to test for lead.
Comparisons for KQ1 were screening vs no screening; for KQ2a, a questionnaire against a reference standard (ie, venous lead level); for KQ2b, capillary vs venous blood lead level testing; and for treatment questions, treatment vs no treatment, placebo, or inactive control.
